Publicaciones en colaboración con investigadores/as de Universidad Complutense de Madrid (11)

2014

  1. Impaired wound repair in adult endoglin heterozygous mice associated with lower NO bioavailability

    Journal of Investigative Dermatology, Vol. 134, Núm. 1, pp. 247-255

2010

  1. The role of the TGF-β coreceptor endoglin in cancer

    TheScientificWorldJournal, Vol. 10, pp. 2367-2384

2005

  1. Matrix metalloproteinase 13 mediates nitric oxide activation of endothelial cell migration

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 102, Núm. 10, pp. 3685-3690

1999

  1. Endoglin is expressed in the chicken vasculature and is involved in angiogenesis

    FEBS Letters, Vol. 459, Núm. 2, pp. 249-254

1993

  1. Volume expansion, natriuresis and atrial natriuretic peptide in type I and type II diabetes

    Cardiovascular Risk Factors, Vol. 3, Núm. 3, pp. 174-180

1991

  1. Atrial natriuretic peptide in patients with acute myocardial infarction without functional heart failure

    European Heart Journal, Vol. 12, Núm. 4, pp. 503-507

1990

  1. Hemodynamic effects of somatostatin in the rat: relationship with plasma glucagon levels

    Heart and Vessels, Vol. 5, Núm. 4, pp. 219-223

1986

  1. Lack of a direct regulatory effect of atrial natriuretic factor on prostaglandins and renin release by isolated rat glomeruli

    Biochemical and Biophysical Research Communications, Vol. 138, Núm. 1, pp. 496-501

1985

  1. Lack of effect of synthetic atrial natriuretic factor on rubidium uptake by human erythrocytes

    Biochemical and Biophysical Research Communications, Vol. 130, Núm. 3, pp. 1066-1071

  2. PLASMA LEVELS OF ATRIAL NATRIURETIC PEPTIDE IN CIRRHOTIC PATIENTS

    The Lancet

1977

  1. VALORACION ESPECTROFLUOROMETRICA DE DOPAMINA EN PEQUENAS AREAS DE CEREBRO DE RATA

    Revista Espanola de Fisiologia, Vol. 33, Núm. 1, pp. 5-10